Andrew Beck’s impressive career has spanned various niches across the radiopharmaceutical development sphere. From utilizing a holistic path for building a successful strategy to the key pairing of pharmaceutical sales and patient advocacy, Andrew understands that an integrated approach is paramount to success. On this episode of Fractals: Life Science Conversations, dig deeper into radiopharmaceutical development and hear Andrew’s key insights on:

• What the radiopharmaceutical “unk-unk” is (and how to navigate running into associated roadblocks),
• Why the simple availability of a product doesn’t necessarily indicate adoption of treatment,
• How beginning with the end in mind is key critical to building a holistic and successful business and/or commercialization strategy,
• Why and how patient advocacy will continue to advance both standard of care and collaborative business strategy.

Listen to Fractals: Life Science Conversations via your preferred podcast service, and contact us today to learn more about working with Andrew and Bracken’s team of expert consultants.